Skip to content

Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway

Influence of PARAmedical Interventions on Patient ACTivation in the Cancer Care Pathway

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03240341
Acronym
PARACT
Enrollment
600
Registered
2017-08-07
Start date
2019-01-28
Completion date
2022-10-20
Last updated
2023-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

The aim is to implement the Patient Activation Measure in paramedical practices as a tool to measure activation of patients in cancer care

Interventions

BEHAVIORALPatient Activation Measure Questionnaire

Measure the level of patient engagement in cancer care pathway

Sponsors

Hôpital Privé de la Loire
CollaboratorUNKNOWN
Centre Hospitalier Emile Roux
CollaboratorOTHER
Clinique de l'infirmerie protestante de Lyon
CollaboratorAMBIG
Institut de Cancérologie de la Loire
CollaboratorOTHER
Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age over 18 years * Cancer patient with an estimated life expectancy of at least one year * Patient requiring immunotherapy or intravenous chemotherapy for any cancer according to the decision of the Multidisciplinary Consultation Meeting * Patient affiliated or entitled to a social security scheme

Exclusion criteria

* Refusal to participate, protected adult patient under guardianship. * Patient disability to understand the course of the study * Patient with documented history of cognitive or psychiatric disorders. * Patient not understanding French

Design outcomes

Primary

MeasureTime frame
Patient Activation Measure Questionnaire12 month

Secondary

MeasureTime frame
Patient Activation Measure Questionnaire6 and 12 months
Visual Analog Scale for confidence level measurement about treatment6 and 12 months
Anxiety and Depression HAD Questionnaire6 and 12 months
REALM Health Literacy Test6 and 12 months
Quality of Life Questionnaire EQ-5D6 and 12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026